Material Agreements

BiomX Inc. entered into Stock Purchase Agreement with Water IO Ltd. valued at $1,250,000 (effective 2026-04-10).

“On April 10, 2026, BiomX Inc. (NYSE American: PHGE) (the “Company”) entered into and simultaneously closed a definitive Stock Purchase Agreement (the “SPA”) with Water IO Ltd. (“Water IO”), a publicly traded Israeli company listed on the Tel Aviv Stock Exchange, pursuant to which the Company acquired 100% of the issued and outstanding share capital of Zorro Net Ltd.”

Spire Global, Inc. entered into Registration Rights Agreement with the Purchasers (effective 2026-04-08).

“in addition, on April 8, 2026, the Company and the Purchasers entered into a registration rights agreement (the “Registration Rights Agreement”), pursuant to which the Company agreed to file the Registration Statement with the SEC on or before April 23, 2026 for purposes of registering the resale of the Shares, to use its reasonable best efforts to have such Registration Statement declared effective no later than May 8, 2026, and to keep the Registration Statement effective until the date that all registrable securities covered by the Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144.”

Spire Global, Inc. entered into Purchase Agreement with certain accredited investors valued at $70.0 million (effective 2026-04-08).

“On April 8, 2026, Spire Global, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), for the private placement (the “Private Placement”) of 5,000,000 shares (the “Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), at a purchase price of $14.00 per Share.”

BOXABL Inc. entered into Second Amendment to the Merger Agreement with FG Merger II Corp. and FG Merger Sub II Inc. valued at Amendment to extend the Agreement End Date from March 31, 2026 to July 31, 2026; release of lock-up (effective 2026-04-06).

“On April 6, 2026, BOXABL Inc. (“ BOXABL ”) entered into a Second Amendment (the “ Second Amendment ”) to that certain Agreement and Plan of Merger, dated as of August 4, 2025, as amended by the First Amendment to the Agreement and Plan of Merger dated November 3, 2025 (collectively, the “ Merger Agreement ”), by and among BOXABL, FG Merger II Corp. (“ FGMC ”), and FG Merger Sub II Inc. (“ Merger Sub ” and together with BOXABL and FGMC, the “ Parties ”).”

NEXTNRG, INC. entered into Leviston SPA with Leviston Resources, LLC valued at principal amount of $1,724,444 (effective 2026-04-01).

“On April 1, 2026, NextNRG, Inc. (the “Company”) and Leviston Resources, LLC (“Leviston”) entered into a Securities Purchase Agreement dated as of April 1, 2026 (the “Leviston SPA”), pursuant to which the Company agreed to sell, and Leviston agreed to purchase, a senior secured convertible promissory note in the principal amount of $1,724,444 (the “Leviston Note”) for a purchase price of $1,552,000.”

Healthcare Triangle, Inc. entered into Platform Development Agreement with SecureKloud Technologies Limited (effective 2026-03-31).

“On April 7, 2026, Healthcare Triangle, Inc., a Delaware corporation (the “ Company ”), entered into a Platform Development Agreement (the “ Agreement ”) with SecureKloud Technologies Limited, an Indian corporation (“ SKL ”), as lead contractor, and Blockedge Technologies Inc., a subsidiary of SKL (“ Blockedge ”), as sub-contractor. The Agreement is made effective as of March 31, 2026.”

Jet.AI Inc. entered into Equity Certificates Subscription Agreement with VERSO Capital 2 SCSP valued at $5,250,000 (effective 2026-04-07).

“Jet.AI Inc. (the “Company”) entered into an Equity Certificates Subscription Agreement (the “Subscription Agreement”) with VERSO Capital 2 SCSP (“Verso”) to subscribe for 8,347 equity certificates (the “Certificates”) in Verso for an aggregate subscription price equal to $5,250,000”

ALPHA MODUS HOLDINGS, INC. entered into Exchange Agreement with the family trust of the Company’s CEO, William Alessi (effective 2026-04-08).

“On April 8, 2026, Alpha Modus Holdings, Inc. (the “ Company ”) entered into an exchange agreement (the “ Exchange Agreement ”) with the family trust of the Company’s CEO, William Alessi, pursuant to which the trust will exchange an aggregate of 3,870,000 shares of Series C Preferred Stock (the “ Preferred Shares ”) for an aggregate of 109,588,265 shares of Class A common stock”

Snail, Inc. entered into Software Development Outsourcing Agreement with Suzhou Snail Digital Technology Co., Ltd. valued at aggregate $1.966 million in four quarterly installments of $491,500 (effective 2026-04-06).

“On April 6, 2026, the Company entered into a Software Development Outsourcing Agreement (the “Development Agreement”) with Suzhou Snail Digital Technology Co., Ltd. (“Suzhou Snail”) through the Company’s wholly-owned subsidiary, Snail Games USA, Inc.”

Snail, Inc. entered into Amendment No. 3 to the Amended and Restated Exclusive Software License Agreement with SDE Inc. valued at reduced licensing fees to $1.5 million per month, replaces certain one-time DLC payments with $5 mil (effective 2026-04-01).

“On April 6, 2026, Snail, Inc., a Delaware corporation, (the “Company”) entered into Amendment No. 3 to the Amended and Restated Exclusive Software License Agreement (the “Amendment”) with SDE Inc., a California corporation (“SDE”) through the Company’s wholly-owned subsidiary, Snail Games USA, Inc.”

FG Merger II Corp. amended Amendment with BOXABL Inc., FG Merger Sub II Inc. (effective 2026-04-06).

“On April 6, 2026, FG Merger II Corp. (“ FGMC ”), entered into an Amendment (the “ Amendment ”) to that certain Agreement and Plan of Merger, dated as of August 4, 2025 (as amended on November 3, 2025, the “ Merger Agreement ”), by and among FGMC, BOXABL Inc., (“ BOXABL ”) and FG Merger Sub II Inc. (“ Merger Sub ” and together with BOXABL and FGMC, the “ Parties ”).”

Stepstone Private Credit Fund LLC terminated MassMutual SPV I Facility with Massachusetts Mutual Life Insurance Company and Massachusetts Ascend Life Insurance Company (effective 2026-04-06).

“On April 6, 2026, SPV Facility I LLC (“SPV Facility I”), a wholly-owned subsidiary of StepStone Private Credit Fund LLC (the “Company”), and the Company executed a termination agreement (the “Termination Agreement”), terminating the Loan and Servicing Agreement”

NEONC TECHNOLOGIES HOLDINGS, INC. entered into Equity Distribution Agreement with BTIG, LLC and A.G.P./Alliance Global Partners valued at $75,000,000 (effective 2026-04-10).

“On April 10, 2026, the Company entered into an Equity Distribution Agreement (the “Agreement”) with BTIG, LLC and A.G.P./Alliance Global Partners (collectively, the “Placement Agents”) to create an “at the market” equity program under which it may sell up to an aggregate of $75,000,000 of shares of the Company’s common stock”

Venture Global, Inc. entered into Term Loan B Facility valued at $1,750,000,000 (effective 2026-04-10).

“entered into a senior secured term loan B facility in an initial principal amount equal to $1,750,000,000 (the “Term Loan B Facility”)”

Dynamix Corp entered into Termination Agreement with Dynamix Corporation, The Ether Machine, Inc., ETH SPAC Merger Sub Ltd., The Ether Reserve LLC, Ethos Sub 1, Inc., Ethos Sub 2, Inc., Ethos Sub 3, Inc., ETH Partners LLC, DynamixCore Holdings, LLC, and the party named on Annex A valued at $50,000,000 (effective 2026-04-08).

“Pursuant to the Termination Agreement, the Payor is required to pay Dynamix $50,000,000 within 15 days of the Effective Date”

Dynamix Corp terminated Sponsor Support Agreement with DynamixCore Holdings, LLC, Dynamix Corporation, The Ether Machine, Inc. (effective 2026-04-08).

“(ii) the Sponsor Support Agreement, dated as of July 21, 2025, by and among the Sponsor, Dynamix and Pubco (the “Sponsor Support Agreement”), in each case pursuant to the terms of the Termination Agreement”

Dynamix Corp terminated Business Combination Agreement with The Ether Machine, Inc., ETH SPAC Merger Sub Ltd., The Ether Reserve LLC, Ethos Sub 1, Inc., Ethos Sub 2, Inc., Ethos Sub 3, Inc., ETH Partners LLC, DynamixCore Holdings, LLC (effective 2026-04-08).

“On April 8, 2026 (the “Effective Date”), Dynamix Corporation, a Cayman Islands exempted company (“Dynamix”), The Ether Machine, Inc., a Delaware corporation (“Pubco”), ETH SPAC Merger Sub Ltd., a Cayman Islands exempted company (“SPAC Merger Sub”), The Ether Reserve LLC, a Delaware limited liability company (the “Company”), Ethos Sub 1, Inc., a Delaware corporation and a wholly owned subsidiary of SPAC (“SPAC Subsidiary A”), Ethos Sub 2, Inc., a Delaware corporation and a wholly owned subsidiary of SPAC Subsidiary A (“SPAC Subsidiary B”), Ethos Sub 3, Inc., a Delaware corporation and a wholly owned subsidiary of SPAC Subsidiary B (“Company Merger Sub” and, together with SPAC Subsidiary A and SPAC Subsidiary B, the “SPAC Subsidiaries” and each, a “SPAC Subsidiary”), ETH Partners LLC, a Delaware limited liability company (the “Seller”), DynamixCore Holdings, LLC, a Delaware limited liability company (the “Sponsor”), and the party named on Annex A thereto (the “Payor”), entered into a Ter”

Aebi Schmidt Holding AG amended Amendment No. 1 to the Relationship Agreement with Peter Spuhler and PCS Holding AG (PCS Parties) (effective 2026-04-07).

“On April 7, 2026, Aebi Schmidt and the PCS Parties entered into Amendment No. 1 to the Relationship Agreement, which amended the Relationship Agreement to, among other things, (i) provide that, if Aebi Schmidt’s Board of Directors (the “Board”) consists of eight members, then the PCS Parties shall have a right to nominate (a) three directors if they own at least 35% of the outstanding shares of Aebi Schmidt common stock, (b) two directors if they own at least 25% (but less than 35%) of the outstanding shares of Aebi Schmidt common stock, (c) two directors if they own at least 15% (but less than 25%) of the outstanding shares of Aebi Schmidt common stock and (d) one director if they own at least 12.5% (but less than 15%) of the outstanding shares of Aebi Schmidt common stock and (ii) allow the Chief Executive Officer of Aebi Schmidt to also hold the position of Chair of the Board.”

Aebi Schmidt Holding AG entered into Relationship Agreement with Peter Spuhler and PCS Holding AG (PCS Parties) (effective 2025-07-01).

“On July 1, 2025, Aebi Schmidt Holding AG (“Aebi Schmidt”), Peter Spuhler and PCS Holding AG (“PCS” and together with Mr. Spuhler, the “PCS Parties”) entered into a Relationship Agreement (the “Relationship Agreement”), which provided certain rights to the PCS Parties in connection with their ownership of Aebi Schmidt common stock, including the right to nominate directors.”

Apogee Acquisition Corp entered into Underwriting Agreement with ARC Group Securities LLC valued at $172,500,000 gross proceeds from sale of 17,250,000 units at $10.00 per unit (effective 2026-04-06).

“the Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration Statement: ● An Underwriting Agreement, dated April 6, 2026, between the Company and ARC Group Securities LLC (the “Representative”), a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K (this “Report”) and incorporated herein by reference”

ACP Holdings Acquisition Corp. entered into Services Agreement with Union Street Sponsor, LLC (effective 2026-04-06).

“A Services Agreement, dated April 6, 2026, between the Company and the Sponsor a copy of which is filed as Exhibit 10.6 to this Report and incorporated herein by reference;”

ACP Holdings Acquisition Corp. entered into Private Placement Units Purchase Agreement with Roth Capital Partners, LLC (effective 2026-04-06).

“A Private Placement Units Purchase Agreement, dated April 6, 2026, between the Company and the Representative, a copy of which is filed as Exhibit 10.5 to this Report and incorporated herein by reference;”

ACP Holdings Acquisition Corp. entered into Private Placement Units Purchase Agreement with Union Street Sponsor, LLC (effective 2026-04-06).

“A Private Placement Units Purchase Agreement, dated April 6, 2026, between the Company and the Sponsor, a copy of which is filed as Exhibit 10.4 to this Report and incorporated herein by reference;”

ACP Holdings Acquisition Corp. entered into Registration Rights Agreement with Union Street Sponsor, LLC and holders signatory thereto (effective 2026-04-06).

“A Registration Rights Agreement, dated April 6, 2026, among the Company, the Sponsor and the holders signatory thereto, a copy of which is filed as Exhibit 10.3 to this Report and incorporated herein by reference;”

ACP Holdings Acquisition Corp. entered into Investment Management Trust Agreement with Odyssey Transfer and Trust Company (effective 2026-04-06).

“An Investment Management Trust Agreement, dated April 6, 2026, between the Company and Odyssey, as trustee, a copy of which is filed as Exhibit 10.2 to this Report and incorporated herein by reference;”

ACP Holdings Acquisition Corp. entered into Letter Agreement with Union Street Sponsor, LLC (effective 2026-04-06).

“A Letter Agreement, dated April 6, 2026, among the Company, its directors and officers and Union Street Sponsor, LLC (the “Sponsor”), a copy of which is filed as Exhibit 10.1 to this Report and incorporated herein by reference;”

ACP Holdings Acquisition Corp. entered into Warrant Agreement with Odyssey Transfer and Trust Company (effective 2026-04-06).

“A Warrant Agreement, dated April 6, 2026, between the Company and Odyssey Transfer and Trust Company (“Odyssey”), as warrant agent, a copy of which is filed as Exhibit 4.1 to this Report and incorporated herein by reference;”

ACP Holdings Acquisition Corp. entered into Underwriting Agreement with Roth Capital Partners, LLC (effective 2026-04-06).

“An Underwriting Agreement, dated April 6, 2026, between the Company and Roth Capital Partners, LLC, as representative of the underwriters named therein (the “Representative”), a copy of which is filed as Exhibit 1.1 to this Current Report on Form 8-K (this “Report”) and incorporated herein by reference;”

DONALDSON Co INC entered into Term Loan Credit Agreement with certain lenders and Wells Fargo Bank, National Association valued at $400 million (effective 2026-04-08).

“On April 8, 2026, Donaldson Company, Inc. (the "Company") entered into a Term Loan Credit Agreement (the "Agreement"), among the Company, certain lenders from time to time party to the Agreement (the "Lenders"), and Wells Fargo Bank, National Association, as administrative agent for the Lenders. The Agreement creates a new three-year committed, unsecured, delayed draw term loan credit facility in the amount of $400 million available to the Company (the "Term Loan Facility").”

HECLA MINING CO/DE/ terminated a notes offering with The Bank of New York Mellon Trust Company, N.A. valued at $263 million 7.25% Senior Notes (effective 2026-04-09).

“On April 9, 2026, Hecla Mining Company (the “Company”) announced it had completed the redemption of its remaining $263 million 7.25% Senior Notes (“Notes”) due in 2028. The full redemption of the Notes terminates the (i) Indenture, dated February 19, 2020, by and among Hecla Mining Company and The Bank of New York Mellon Trust Company, N.A., as trustee (“Indenture”), (ii) First Supplemental Indenture, dated February 19, 2020, and (iii) Second Supplemental Indenture, dated February 6, 2023.”

AIM ImmunoTech Inc. amended Amendment No. 1 with Maxim Group LLC (effective 2026-04-10).

“On April 10, 2026, AIM ImmunoTech Inc. (the “Company”) entered into Amendment No. 1 (the “Amendment”) to that certain Equity Distribution Agreement dated April 1, 2025 (the “Sales Agreement”) with Maxim Group LLC (“Maxim”) to act as the Company’s exclusive sales agent with respect to the issuance and sale of up to $3,000,000 of the Company’s shares of common stock, par value $0.001 per share (the “Shares”), from time to time, in an at-the-market public offering (the “Offering”).”

SEALED AIR CORP/DE terminated Amended and Restated Receivables Loan Agreement with Coöperatieve Rabobank U.A. valued at Repaid all indebtedness (effective 2026-04-09).

“Concurrently with the occurrence of the Effective Time, the Company repaid all indebtedness related to each of the following receivables securitization agreements: (i) the Amended and Restated Receivables Loan Agreement, dated as of December 2, 2021, among Sealed Air Securitization DAC, as borrower, Sealed Air Limited, as servicer, and Coöperatieve Rabobank U.A. trading as Rabobank London, as administrative agent and funding agent and the Company, as performance undertaking provider; and (ii) the Ninth Amended and Restated Receivables Purchase Agreement, dated as of December 12, 2025, by and among Sealed Air Funding LLC, as seller, Sealed Air Corporation (US), as collection agent, and Credit Agricole Corporate and Investment Bank, as administrative agent and Coöperatieve Rabobank U.A., as a committed purchaser and a managing agent.”

SEALED AIR CORP/DE terminated 1.573% Senior Notes due 2026 with Noteholders valued at Redeemed or satisfied and discharged in full (effective 2026-04-09).

“Concurrently with the occurrence of the Effective Time, the Company redeemed or satisfied and discharged in full its (i) 1.573% Senior Notes due 2026, (ii) 4.000% Senior Notes due 2027, (iii) 6.125% Senior Notes due 2028, (iv) 5.000% Senior Notes due 2029, (v) 7.250% Senior Notes due 2031 and (vi) 6.500% Senior Notes due 2032.”

SEALED AIR CORP/DE terminated Fifth Amended and Restated Syndicated Facility Agreement with Bank of America, N.A. valued at Terminated and repaid all credit commitments (effective 2026-04-09).

“At the Effective Time, the Company repaid, or caused to be repaid, all credit commitments outstanding under that certain Fifth Amended and Restated Syndicated Facility Agreement, dated as of October 31, 2025, by and among the Company, as Borrower Representative, the other Borrowers from time to time party thereto, the lenders from time to time party thereto and Bank of America, N.A., as agent.”

Awaysis Capital, Inc. entered into Credit Facility with Belize Bank Limited valued at BZD $4,103,000 (approximately US $2,051,500 at an exchange rate of .50 United States dollar for 1 Be (effective 2026-04-03).

“On April 3, 2026, Awaysis Belize Limited, a wholly owned subsidiary of Awaysis Capital, Inc. (the “Company”), entered into a credit facility letter and related agreements (collectively, the “Credit Facility”) with Belize Bank Limited (the “Bank”) and issued a secured promissory note (the “Note”) in connection therewith.”

Prairie Operating Co. entered into Letter Agreement with Hudson Bay PH XIX LLC (High Trail) (effective 2026-04-08).

“On April 8, 2026, Prairie Operating Co. (the "Company") entered into a letter agreement (the "Letter Agreement") with Hudson Bay PH XIX LLC ("High Trail")”

Whitestone REIT entered into Agreement and Plan of Merger with AREG Wizard Parent LP, AREG Wizard Intermediate LP, AREG Wizard Operating Partnership LP valued at $19.00 (effective 2026-04-08).

“with the Company, the “Company Parties”), AREG Wizard Parent LP (“Parent”), AREG Wizard Intermediate LP (“Merger Sub”), and AREG Wizard Operating Partnership LP (“Merger OP” and, collectively with Parent and Merger Sub, the “Parent Parties”), entered into an Agreement and Plan of Merger (the “Merger Agreement”). The Merger Agreement provides that, upon the terms and subject to the conditions set forth therein and in accordance with the Maryland REIT Law and the Delaware Revised Uniform Limited Partnership Act, Merger OP will merge with and into the Operating Partnership (the “Partnership Merger”), and, immediately following the Partnership Merger, the Company will merge with and into Merger Sub (the “Company Merger” and, together with the Partnership Merger, the “Mergers”).”

Sonoma Pharmaceuticals, Inc. entered into Manufacturing and Supply Agreement with Kenvue Brands LLC (effective 2025-10-24).

“On April 8, 2026, we entered into a Manufacturing and Supply Agreement with Kenvue Brands LLC for the sale of Microcyn ® technology-based products in the United States.”

Main Street Capital CORP entered into Master Note Purchase Agreement with certain qualified institutional investors valued at $150,000,000 6.93% Series A Senior Notes due April 15, 2031 (effective 2026-04-08).

“On April 8, 2026, Main Street Capital Corporation (“Main Street”) and certain qualified institutional investors entered into a Master Note Purchase Agreement (the “Note Purchase Agreement”), which governs the issuance of $150,000,000 in aggregate principal amount of 6.93% Series A Senior Notes due April 15, 2031 (the “Series A Notes”).”

Forte Biosciences, Inc. entered into Underwriting Agreement with Guggenheim Securities, LLC valued at approximately $150 million (effective 2026-04-08).

“On April 8, 2026, Forte Biosciences, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Guggenheim Securities, LLC as representative (the “Representative”) of the several underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale in a public offering (the “Offering”) of 5,709,936 shares of the Company’s common stock, par value $0.001 per share, at a price to the public of $26.27 per share (the “Shares”).”

C4 Therapeutics, Inc. entered into "License Agreement" with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (together, "Roche") valued at $20.0 million upfront, over $1.0 billion in aggregate milestone payments (effective 2026-04-08).

“On April 8, 2026 , C4 Therapeutics, Inc. (“ C4T ”) entered into a Research Collaboration and License Agreement ( the “ License Agreement ”) with F. Hoffmann-La Roche Ltd. (“ Roche Basel ”) and Hoffmann-La Roche Inc. (“ Roche US ”, and together with Roche Basel, “ Roche ”) to collaborate on the discovery, development and commercialization of degrader-antibody conjugates (" DACs ")”

International Seaways, Inc. amended Second A&R Rights Agreement with Computershare Trust Company, N.A. (effective 2026-04-09).

“On April 9, 2026, International Seaways, Inc. (the “Company”) amended and restated the Amended and Restated Rights Agreement, dated as of April 11, 2023, by and between the Company and Computershare Trust Company, N.A., as rights agent, to extend the “Final Expiration Date” to April 8, 2029 and increase the “Purchase Price” from $50 to $95.”

Ovintiv Inc. terminated Two-Year Term Credit Agreement with JPMorgan Chase Bank, N.A., Toronto Branch valued at C$1.57 billion (effective 2026-04-10).

“As previously disclosed, on November 25, 2025, Ovintiv Canada ULC (“Ovintiv Canada”) entered into a Two-Year Term Credit Agreement by and among Ovintiv Canada, as borrower, Ovintiv Inc. (“Ovintiv”), as parent, JPMorgan Chase Bank, N.A., Toronto Branch, as administrative agent, and the lenders party thereto (the “Credit Agreement”), to finance the cash consideration for the acquisition of all the outstanding common shares of NuVista Energy Ltd. (“NuVista”), which closed on February 3, 2026. Following the closing of the Anadarko Sale (defined below), Ovintiv intends to repay C$1.57 billion under the Credit Agreement plus applicable interest on April 10, 2026, representing all outstanding obligations thereunder, and will terminate the Credit Agreement.”

Assertio Holdings, Inc. entered into Agreement and Plan of Merger with Garda Therapeutics, Inc. valued at $18.00 per share of Common Stock in cash, plus one contingent value right per share (effective 2026-04-08).

“On April 8, 2026, Assertio Holdings, Inc. (the " Company " or " Assertio ") entered into an Agreement and Plan of Merger (the " Merger Agreement ") with Garda Therapeutics, Inc., a Delaware corporation (" Parent "), and Audi Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (" Purchaser ").”

Assertio Holdings, Inc. entered into Merger Agreement with Garda Therapeutics, Inc. (Parent) and Audi Merger Sub, Inc. (Purchaser) (effective 2026-04-08).

“On April 8, 2026, Assertio Holdings, Inc. (the " Company " or " Assertio ") entered into an Agreement and Plan of Merger (the " Merger Agreement ") with Garda Therapeutics, Inc., a Delaware corporation (" Parent "), and Audi Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (" Purchaser ").”

Constellation Acquisition Corp I entered into Business Combination Agreement with HiTech Minerals Inc. valued at an equity value of $500 million (effective 2026-04-09).

“On April 9, 2026, Constellation Acquisition Corp I, a Cayman Islands exempted company (“CSTA”), US Elemental Inc., a Delaware corporation (“PubCo”), CAC Merger Sub I LLC, a Delaware limited liability company and a direct wholly owned subsidiary of PubCo (“Merger Sub 1”), USE Merger Sub 2 Inc., a Nevada corporation (“Merger Sub 2”), and HiTech Minerals Inc., a Nevada corporation (“HiTech”), entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”).”

OSR Holdings, Inc. entered into Note Purchase Agreement with White Lion Capital, LLC valued at principal amount of $1,055,555.55 Senior Secured Convertible Promissory Note; Company received $500, (effective 2026-04-07).

“Also on April 7, 2026, the Company entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with White Lion, pursuant to which the Company agreed to issue a Senior Secured Convertible Promissory Note in the principal amount of $1,055,555.55 (the “Note”).”

OSR Holdings, Inc. entered into Amendment No. 2 to the Common Stock Purchase Agreement with White Lion Capital, LLC valued at introduces additional purchase mechanisms including intraday purchase notices and fixed purchase not (effective 2026-04-07).

“On April 7, 2026, OSR Holdings, Inc. (the “Company”) entered into Amendment No. 2 to the Common Stock Purchase Agreement (the “ELOC Amendment”) with White Lion Capital, LLC, d/b/a White Lion GBM Innovation Fund (“White Lion”), which amends that certain Common Stock Purchase Agreement, dated February 25, 2025, as previously amended.”

Digi Power X Inc. amended ATM Agreement with A.G.P. / Alliance Global Partners valued at up to US$75 million (effective 2026-04-09).

“On April 9, 2026, the Company entered into an amended and restated sales agreement with the Agent (the “ATM Agreement”), which amends and restates the Original ATM Agreement in its entirety.”

Definitive Healthcare Corp. terminated Nominating Agreement with SE VII DHC AIV, L.P. (effective 2026-04-03).

“the Company and Spectrum entered into a termination agreement that permanently and irrevocably terminated the Nominating Agreement in its entirety.”